L & S Advisors Inc Sarepta Therapeutics, Inc. Transaction History

L & S Advisors Inc

$771 Million
Q1 2024

A detailed history of L & S Advisors Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, L & S Advisors Inc holds 13,594 shares of SRPT stock, worth $2.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

13,594

Previous 14,392 5.54%

Holding current value

$2.1 Million

Previous $1.39 Million 26.82%

% of portfolio

0.23%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$93.7 - $141.53 $74,772 - $112,940	-798 Reduced 5.54%	13,594 $1.76 Million
Q4 2023 Feb 13, 2024	BUY	$67.31 - $124.76 $6,596 - $12,226	98 Added 0.69%	14,392 $1.39 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $397,700 - $479,529	3,880 Added 37.26%	14,294 $1.73 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $329,733 - $487,131	3,099 Added 42.37%	10,414 $1.19 Million
Q1 2023 May 10, 2023	SELL	$117.53 - $155.99 $332,492 - $441,295	-2,829 Reduced 27.89%	7,315 $1.01 Million

Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $137,472 - $180,093	-1,363 Reduced 11.84%	10,144 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $871,194 - $1.37 Million	11,507 New	11,507 $1.27 Million
Q1 2021 May 10, 2021	SELL	$72.25 - $168.95 $1.28 Million - $3 Million	-17,751 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $1 Million - $1.43 Million	7,995 Added 81.95%	17,751 $3.03 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $225,002 - $305,041	-1,770 Reduced 15.36%	9,756 $1.37 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $72,912 - $134,612	-784 Reduced 6.37%	11,526 $1.85 Million
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $122,993 - $196,538	-1,493 Reduced 10.82%	12,310 $1.2 Million
Q4 2019 Feb 13, 2020	SELL	$76.53 - $135.58 $8,035 - $14,235	-105 Reduced 0.75%	13,803 $1.78 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $81,911 - $176,523	1,125 Added 8.8%	13,908 $1.05 Million
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $68,448 - $92,689	-610 Reduced 4.55%	12,783 $1.94 Million
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $48,534 - $69,014	455 Added 3.52%	13,393 $1.6 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $80,289 - $122,726	825 Added 6.81%	12,938 $1.41 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $45,893 - $64,280	398 Added 3.4%	12,113 $1.96 Million
Q2 2018 Aug 13, 2018	SELL	$71.74 - $153.69 $7,030 - $15,061	-98 Reduced 0.83%	11,715 $1.55 Million
Q1 2018 May 14, 2018	BUY	$54.02 - $82.27 $177,077 - $269,681	3,278 Added 38.41%	11,813 $875,000
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $406,607 - $484,361	8,535	8,535 $475,000

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.5B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.

Account